Texas Reglan Tardive Dyskenesia Case Removed to Federal Court

W.L. Meyers | August 7th, 2012 | Posted in Reglan Lawsuit News
Reglan Gavel Smash

A Reglan side effects lawsuit pending in Texas has been removed to federal court after it was determined that the facts of the case meet all requirements of federal diversity jurisdiction. The motion was made at the defendants’ request after the case was denied inclusion in a Reglan mass tort currently pending in Philadelphia. In the original complaint filed in… Read more »

Reglan Induced Parkinson’s Disease and Tardive Dyskinesia

Emma Gonzalez | July 26th, 2012 | Posted in Reglan Lawsuit News
Reglan Parkinsons

Reglan, which is prescribed to treat GERD (gastroesophageal reflux disease), acid reflux and other digestive problems, works by reducing a patient’s dopamine levels. Dopamine is a neurotransmitter, meaning that it carries signals from the brain to other parts of the body, thus regulating a person’s bodily functions. As a result of lowered dopamine levels, a reported 15%-61% of patients develop… Read more »

Warnings About Reglan Tardive Dyskinesia Come Two Years Later in Canada

Shay Morrigan | July 18th, 2012 | Posted in Reglan Lawsuit News
Reglan Black Box Warning

On February 26, 2009, the FDA issued a press release stating that they were requiring a black box warning on the heartburn drug Reglan (metoclopramide). The warning alerted physicians and consumers to the potential increased risk of Reglan neurological side effects associated with long-term ingestion of the drug, particularly the serious movement disorder called tardive dyskinesia. About two years later,… Read more »

Oregon Plaintiff Claims Neurological Side Effects From Reglan

Shay Morrigan | July 10th, 2012 | Posted in Reglan Lawsuit News
Reglan Tardive Dyskinesia

Oregon resident Joyce Klopp filed a new Reglan side effects lawsuit on June 26, 2012, in the Superior Court of California, San Francisco. Klopp seeks to hold manufacturers liable for injuries she suffered after taking the heartburn drug. Klopp names both name-brand manufacturer of Reglan Wyeth LLC and generic manufacturers Schwarz Pharma and Teva Pharmaceuticals as defendants in her case…. Read more »

Reglan Side Effects Include Tardive Dyskinesia & Other Movement Disorders

Shay Morrigan | July 3rd, 2012 | Posted in Reglan Lawsuit News
Reglan Tardive Dyskinesia

Approved by the FDA in 1985, Reglan (metoclopramide) has long been used to treat heartburn, gastroesophageal reflux disease (GERD), and nausea and vomiting related to cancer treatments. In 2009, however, the FDA required all manufacturers of metoclopramide to add a black box warning to the drug labels alerting physicians and patients to the risks associated with long-term or high-dose use…. Read more »